Page last updated: 2024-10-25

indibulin and Carcinoma, Non-Small Cell Lung

indibulin has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

indibulin: Tubulin Modulator/Antineoplastic Agent; structure in first source

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Leu, JD	3
Lin, ST	3
Chen, CT	3
Chang, CA	3
Lee, YJ	3

Other Studies

1 other study available for indibulin and Carcinoma, Non-Small Cell Lung

Article	Year
BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways. International journal of molecular sciences, 2022, Nov-15, Volume: 23, Issue:22 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Indoles; Lung Neoplasms; Microtubules; Rad	2022
BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways. International journal of molecular sciences, 2022, Nov-15, Volume: 23, Issue:22 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Indoles; Lung Neoplasms; Microtubules; Rad	2022
BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways. International journal of molecular sciences, 2022, Nov-15, Volume: 23, Issue:22 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Indoles; Lung Neoplasms; Microtubules; Rad	2022
BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways. International journal of molecular sciences, 2022, Nov-15, Volume: 23, Issue:22 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Indoles; Lung Neoplasms; Microtubules; Rad	2022
BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways. International journal of molecular sciences, 2022, Nov-15, Volume: 23, Issue:22 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Indoles; Lung Neoplasms; Microtubules; Rad	2022
BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways. International journal of molecular sciences, 2022, Nov-15, Volume: 23, Issue:22 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Indoles; Lung Neoplasms; Microtubules; Rad	2022
BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways. International journal of molecular sciences, 2022, Nov-15, Volume: 23, Issue:22 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Indoles; Lung Neoplasms; Microtubules; Rad	2022
BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways. International journal of molecular sciences, 2022, Nov-15, Volume: 23, Issue:22 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Indoles; Lung Neoplasms; Microtubules; Rad	2022
BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways. International journal of molecular sciences, 2022, Nov-15, Volume: 23, Issue:22 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Indoles; Lung Neoplasms; Microtubules; Rad	2022